US Patent 9290565 Immunogenic composition
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+330 characters)
Article
Patent abstract
The present invention relates to fusion proteins comprising fragments of toxin A and toxin B from Clostridium difficile, such as wherein the first fragment and the second fragment are adjacent to one another and wherein the first repeat portion and the second repeat portion have sequence similarity to one another.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09290565 Immunogenic composition US Patent 9290565 Immunogenic composition
Infobox
Patent Number
0929056500
Patent Number
929056500
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
092905650
Date of Patent
March 22, 2016
0Patent Application Number
141226900
Date Filed
May 25, 2012
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
092905650
Date of Patent
March 22, 2016
0Patent Application Number
141226900
Date Filed
May 25, 2012
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09290565 Immunogenic composition
Infobox
Is a
Patent jurisdiction
Patent number
09290565
Date of patent
March 22, 2016
Patent application number
14122690
Date Filed
May 25, 2012
Patent primary examiner
Find more entities like US Patent 9290565 Immunogenic composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
